Approval · Notice of Compliance 35737 · 2025
SOLVEZINE: Notice of Compliance 35737
Issued July 25, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35737
- Date
- July 25, 2025
- Company
- Norbrook Laboratories Ltd.Newry, Northern Ireland, United Kingdom
- Product type
- Veterinary
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Administrative - Change in brand name
- Canadian reference product
- BANAMINE (Intervet Canada Corp)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SOLVEZINE | 02234061 | Marketed |
Medicinal ingredients
- FLUNIXIN MEGLUMINE 50 MG per ML